V
Victor Asensi
Researcher at International Sleep Products Association
Publications - 133
Citations - 2814
Victor Asensi is an academic researcher from International Sleep Products Association. The author has contributed to research in topics: Medicine & Viral load. The author has an hindex of 25, co-authored 119 publications receiving 2540 citations. Previous affiliations of Victor Asensi include University of Oviedo & Services Hospital.
Papers
More filters
Journal ArticleDOI
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.
Luz Martín-Carbonero,Yves Benhamou,Massimo Puoti,Juan Berenguer,José Mallolas,Carmen Quereda,Ana Arizcorreta,Antonio Gonzalez,Jürgen K. Rockstroh,Victor Asensi,Pilar Miralles,Montse Laguno,Leonor Moreno,José A. Girón,Martin Vogel,Javier García-Samaniego,Marina Núñez,Miriam Romero,Santiago Moreno,Juan José de la Cruz,Vincent Soriano +20 more
TL;DR: Severe liver fibrosis is frequently found in HCV-HIV-coinfected patients with elevated serum ALT levels, and its severity increases significantly with age, and the rate of complications due to end-stage liver disease will inevitably increase in this population, for whom anti-HCV therapy should be considered a priority.
Journal ArticleDOI
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C
Javier García-Samaniego,Manuel Torralbo Rodríguez,Juan Berenguer,Rafael Rodríguez-Rosado,J. Carbo,Victor Asensi,Vicente Soriano +6 more
TL;DR: HCC seems to occur at a younger age and after a shorter period of HCV infection in subjects coinfected with HIV, and in those with HCV-related cirrhosis the periodic monitoring of α-fetoprotein and abdominal ultrasonography should be recommended.
Journal ArticleDOI
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
Marina Núñez,Celia Miralles,Miguel Angel Berdún,Elena Losada,Koldo Aguirrebengoa,Antonio Ocampo,Piedad Arazo,Manuel Cervantes,Ignacio Santos,Santiago Echeverría,María José Galindo,Victor Asensi,Pablo Barreiro,Julio Sola,Juan Jose Hernandez-Burruezo,Josep M. Guardiola,Miriam Romero,Javier García-Samaniego,Vincent Soriano +18 more
TL;DR: The use of RBV 1000-1200 mg/day plus pegIFN is relatively safe and provides SVR in nearly half of coinfected patients, twice as high in HCV-2/3 thanHCV-1/4.
Journal ArticleDOI
Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
TL;DR: Women have more favourable clinical and viroimmunological patterns than men both at baseline and during antiretroviral treatment, and sex has a small but significant influence on the clinical and laboratory outcomes of HIV infection.
Journal ArticleDOI
Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments
A Rodriguez Guardado,Armando Blanco,Victor Asensi,Federico Perez,J C Rial,V Pintado,E. Bustillo,M Lantero,E Tenza,Maria Elena Alvarez,Maradona Ja,José A. Carton +11 more
TL;DR: Combined therapy with iv and intrathecal colistin is a useful and safe option in the treatment of nosocomial Acinetobacter meningitis.